BLUEPRINT MEDICINES CORP (BPMC)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$129
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $129 | 1 | 0.00% | 25q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $129 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 2 | $38.6K | 301 | 1 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $2.7K | 25,884 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 3 | $11.6K | 90 | 0 | 1 | 2 | 0.0% |
| Q2 2025 | 332 | $8.5B | 63,575,103 | 99 | 84 | 109 | 4.1% |
| Q1 2025 | 330 | $5.7B | 62,256,620 | 65 | 113 | 108 | 4.2% |
| Q4 2024 | 319 | $5.5B | 60,349,868 | 40 | 135 | 86 | 5.0% |
| Q3 2024 | 295 | $5.8B | 59,144,411 | 48 | 128 | 74 | 5.8% |
| Q2 2024 | 284 | $6.8B | 59,499,999 | 41 | 98 | 92 | 6.3% |
| Q1 2024 | 261 | $6.0B | 60,524,995 | 46 | 92 | 79 | 3.8% |
| Q4 2023 | 239 | $5.6B | 58,177,211 | 52 | 62 | 84 | 4.1% |
| Q3 2023 | 196 | $2.9B | 56,562,194 | 23 | 83 | 51 | 1.8% |
| Q2 2023 | 199 | $3.6B | 55,578,189 | 27 | 67 | 65 | 1.5% |
| Q1 2023 | 189 | $2.9B | 64,060,414 | 26 | 78 | 51 | 1.2% |
| Q4 2022 | 177 | $2.2B | 50,266,900 | 26 | 67 | 48 | 1.1% |
| Q3 2022 | 235 | $4.2B | 63,016,002 | 38 | 68 | 80 | 0.9% |
| Q2 2022 | 231 | $3.2B | 63,259,850 | 35 | 77 | 82 | 1.2% |
| Q1 2022 | 244 | $3.8B | 59,813,317 | 30 | 83 | 87 | 0.5% |
| Q4 2021 | 281 | $6.4B | 59,168,404 | 23 | 95 | 104 | 0.4% |
| Q3 2021 | 289 | $6.2B | 59,640,511 | 39 | 94 | 92 | 0.9% |
| Q2 2021 | 281 | $5.2B | 58,627,481 | 50 | 106 | 67 | 0.5% |
| Q1 2021 | 266 | $5.7B | 58,515,240 | 32 | 101 | 88 | 0.5% |
| Q4 2020 | 282 | $6.6B | 58,118,042 | 58 | 74 | 98 | 1.6% |
| Q3 2020 | 239 | $5.3B | 57,270,303 | 27 | 81 | 82 | 1.0% |
| Q2 2020 | 236 | $4.5B | 56,366,991 | 46 | 82 | 66 | 2.3% |
| Q1 2020 | 218 | $3.3B | 55,354,660 | 37 | 94 | 55 | 2.0% |
| Q4 2019 | 230 | $4.2B | 51,434,806 | 34 | 67 | 74 | 2.3% |
| Q3 2019 | 222 | $3.9B | 52,082,630 | 26 | 86 | 55 | 3.0% |
| Q2 2019 | 223 | $4.9B | 49,744,139 | 56 | 93 | 44 | 3.8% |
| Q1 2019 | 203 | $3.9B | 48,803,296 | 48 | 60 | 58 | 0.8% |
| Q4 2018 | 163 | $2.5B | 46,216,705 | 2 | 1 | 2 | 0.7% |